Company intelligence / Profile preview

Durbin

London, United Kingdom
Ownership
Private
Employees
~3300
Development stage
Other
01

Overview

Durbin is a global supplier of pharmaceuticals, medical equipment, and consumables, primarily focused on logistics, access, and distribution rather than drug R&D. The company specializes in supplying unlicensed/specialty medicines, clinical trial comparators, and medical solutions to healthcare systems, with no proprietary clinical-stage drug development activities reported.

Industry
Contract Research Organization
02

Partnerships

All top 30 global pharmaceutical companiesNumerous research-based biotech companies

Beyond the preview

Go deeper on Durbin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Durbin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call